Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00787865 · ClinicalTrials.gov registry record
Diffusion Tensor Imaging (DTI) in Infants With Krabbe Disease
A clinical trial of Krabbe Disease, sponsored by University of Pittsburgh.
- Active
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT00787865 is a study of Krabbe Disease that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 100 participants, below the 394-participant average among 4 other Krabbe Disease trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00787865, a study of Krabbe Disease, is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to learn about early brain development in children with Krabbe disease, and to use diffusion tensor imaging as an early diagnostic tool to identify newborns at risk for the disease.
Conditions Studied
Study Locations (1)
Pennsylvania
- UPMC Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2008-04 |
| Est. Completion | 2027-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00787865
The ClinicalTrials.gov registry entry for NCT00787865 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 394-participant average among 4 other Krabbe Disease trials with a reported enrollment target (75% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Krabbe Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00787865 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00787865 about?
NCT00787865 is a clinical study titled "Diffusion Tensor Imaging (DTI) in Infants With Krabbe Disease". This study is designed to learn about early brain development in children with Krabbe disease, and to use diffusion tensor imaging as an early diagnostic tool to identify newborns at risk for the disease.
What is the current status of trial NCT00787865?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2008-04. Estimated completion is 2027-04.
What conditions does trial NCT00787865 study?
This clinical trial studies the following conditions: Krabbe Disease.
Who is sponsoring clinical trial NCT00787865?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00787865 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Krabbe Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Krabbe Disease Global Patient Registry
RECRUITING
-
Longitudinal Study of Neurodegenerative Disorders
RECRUITING
-
Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT
ACTIVE NOT RECRUITING · Phase 1
-
Gene Transfer Clinical Trial for Krabbe Disease
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.